161 related articles for article (PubMed ID: 25688924)
1. 'We had to change to single beds because I itch in the night': a qualitative study of the experiences, attitudes and approaches to coping of patients with cutaneous T-cell lymphoma.
Beynon T; Selman L; Radcliffe E; Whittaker S; Child F; Orlowska D; Morgans C; Morris S; Harding R
Br J Dermatol; 2015 Jul; 173(1):83-92. PubMed ID: 25688924
[TBL] [Abstract][Full Text] [Related]
2. 'We're all carrying a burden that we're not sharing': a qualitative study of the impact of cutaneous T-cell lymphoma on the family.
Selman LE; Beynon T; Radcliffe E; Whittaker S; Orlowska D; Child F; Harding R
Br J Dermatol; 2015 Jun; 172(6):1581-1592. PubMed ID: 25546238
[TBL] [Abstract][Full Text] [Related]
3. 'It's a traumatic illness, traumatic to witness': a qualitative study of the experiences of bereaved family caregivers of patients with cutaneous T-cell lymphoma.
Orlowska D; Selman LE; Beynon T; Radcliffe E; Whittaker S; Child F; Harding R
Br J Dermatol; 2018 Oct; 179(4):882-888. PubMed ID: 29451670
[TBL] [Abstract][Full Text] [Related]
4. Significant impact of cutaneous T-cell lymphoma on patients' quality of life: results of a 2005 National Cutaneous Lymphoma Foundation Survey.
Demierre MF; Gan S; Jones J; Miller DR
Cancer; 2006 Nov; 107(10):2504-11. PubMed ID: 17048251
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality-of-life assessment in patients with cutaneous T-cell lymphoma.
Demierre MF; Tien A; Miller D
Arch Dermatol; 2005 Mar; 141(3):325-30. PubMed ID: 15781673
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and severity of pruritus and quality of life in patients with cutaneous T-cell lymphoma.
Wright A; Wijeratne A; Hung T; Gao W; Whittaker S; Morris S; Scarisbrick J; Beynon T
J Pain Symptom Manage; 2013 Jan; 45(1):114-9. PubMed ID: 22917715
[TBL] [Abstract][Full Text] [Related]
7. Qualitative accounts of living with cutaneous T-cell lymphoma.
Barke J
Br J Dermatol; 2015 Jul; 173(1):10-1. PubMed ID: 26174639
[No Abstract] [Full Text] [Related]
8. Illness Perception in Primary Cutaneous T-cell Lymphomas: What Patients Believe About Their Disease.
Eder J; Kammerstätter M; Erhart F; Mairhofer-Muri D; Trautinger F
Acta Derm Venereol; 2016 Mar; 96(3):381-5. PubMed ID: 26392387
[TBL] [Abstract][Full Text] [Related]
9. Current measures are not sufficient: an interview-based qualitative assessment of quality of life in cutaneous T-cell lymphoma.
Bhat TS; Herbosa CM; Rosenberg AR; Sogade O; Jeffe DB; Mehta-Shah N; Semenov YR; Musiek AC
Br J Dermatol; 2021 Feb; 184(2):310-318. PubMed ID: 32510571
[TBL] [Abstract][Full Text] [Related]
10. Patients' Illness Perception as a Tool to Improve Individual Disease Management in Primary Cutaneous Lymphomas.
Porkert S; Lehner-Baumgartner E; Valencak J; Knobler R; Riedl E; Jonak C
Acta Derm Venereol; 2018 Feb; 98(2):240-245. PubMed ID: 29048099
[TBL] [Abstract][Full Text] [Related]
11. Acitretin for the treatment of cutaneous T-cell lymphoma.
Cheeley J; Sahn RE; DeLong LK; Parker SR
J Am Acad Dermatol; 2013 Feb; 68(2):247-54. PubMed ID: 22917895
[TBL] [Abstract][Full Text] [Related]
12. What are the supportive and palliative care needs of patients with cutaneous T-cell lymphoma and their caregivers? A systematic review of the evidence.
Beynon T; Radcliffe E; Child F; Orlowska D; Whittaker S; Lawson S; Selman L; Harding R
Br J Dermatol; 2014 Mar; 170(3):599-608. PubMed ID: 24116897
[TBL] [Abstract][Full Text] [Related]
13. Non-random geographic distribution of patients with cutaneous T-cell lymphoma in the Greater Pittsburgh Area.
Moreau JF; Buchanich JM; Geskin JZ; Akilov OE; Geskin LJ
Dermatol Online J; 2014 Jul; 20(7):. PubMed ID: 25046454
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and severity of pruritus in cutaneous T cell lymphoma.
Vij A; Duvic M
Int J Dermatol; 2012 Aug; 51(8):930-4. PubMed ID: 22788808
[TBL] [Abstract][Full Text] [Related]
15. Chronic pruritus--more than a symptom: a qualitative investigation into patients' subjective illness perceptions.
Bathe A; Weisshaar E; Matterne U
J Adv Nurs; 2013 Feb; 69(2):316-26. PubMed ID: 22571475
[TBL] [Abstract][Full Text] [Related]
16. A qualitative assessment of psychosocial impact, coping and adjustment in high-risk melanoma patients and caregivers.
Tan JD; Butow PN; Boyle FM; Saw RP; O'Reilly AJ
Melanoma Res; 2014 Jun; 24(3):252-60. PubMed ID: 24584097
[TBL] [Abstract][Full Text] [Related]
17. Pruritus in cutaneous T-cell lymphoma: a review.
Ahern K; Gilmore ES; Poligone B
J Am Acad Dermatol; 2012 Oct; 67(4):760-8. PubMed ID: 22285672
[TBL] [Abstract][Full Text] [Related]
18. Improved pruritus correlates with lower levels of IL-31 in CTCL patients under different therapeutic modalities.
Cedeno-Laurent F; Singer EM; Wysocka M; Benoit BM; Vittorio CC; Kim EJ; Yosipovitch G; Rook AH
Clin Immunol; 2015 May; 158(1):1-7. PubMed ID: 25762519
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma.
Wu K; Lund M; Bang K; Thestrup-Pedersen K
Cancer; 1999 Sep; 86(6):1056-63. PubMed ID: 10491534
[TBL] [Abstract][Full Text] [Related]
20. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
Vidulich KA; Talpur R; Bassett RL; Duvic M
Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
